Skip to main content
. 2021 Jun 22;13(7):925. doi: 10.3390/pharmaceutics13070925

Figure 1.

Figure 1

Pharmacological targeting of STAT3 pathway by small-molecule inhibitor Stattic ameliorates clinical symptoms of EAE in SJL/J mice: (A) Clinical scores during the experiment; (B) AUC from day 0 to 30; (C) clinical scores at the end of the study. Data are expressed as mean ± SEM, n = 6–8/group. # p < 0.05 vs. Veh + EAE SJL/J group.